The impact of topiramate, botulinum toxin type A, and CGRP-antibodies on medication overuse headache in patients with chronic migraine: A protocol for systematic review and meta-analysis.
Saved in:
| Title: | The impact of topiramate, botulinum toxin type A, and CGRP-antibodies on medication overuse headache in patients with chronic migraine: A protocol for systematic review and meta-analysis. |
|---|---|
| Authors: | Giri, Samita1 (AUTHOR) samita.giri@ntnu.no, Tronvik, Erling1,2 (AUTHOR), Linde, Mattias2 (AUTHOR), Hagen, Knut1,3 (AUTHOR) |
| Source: | Cephalalgia Reports. 4/28/2022, Vol. 5, p1-8. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
